Genolution (XKRX:225220) ROCE % : -0.07% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genolution ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Genolution's annualized ROCE % for the quarter that ended in Mar. 2024 was -0.07%.

Genolution ROCE % Historical Data

The historical data trend for Genolution's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genolution ROCE % Chart

Genolution Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-6.53

118.41

58.20

18.27

-6.65

Genolution Quarterly Data
	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															3.53	-5.84	-1.52	-22.55	-0.07

Genolution ROCE % Calculation

Genolution's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-7091.386	/	( ( (114453.735 - 4643.596)	+	(113437.822 - 10075.179) )	/ 2 )
	=	-7091.386	/	( (109810.139	+	103362.643)	/ 2 )
	=	-7091.386	/	106586.391
	=	-6.65 %

Genolution's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-73.928	/	( ( (113437.822 - 10075.179)	+	(114774.581 - 10885.711) )	/ 2 )
	=	-73.928	/	( ( 103362.643	+	103888.87 )	/ 2 )
	=	-73.928	/	103625.7565
	=	-0.07 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Genolution (XKRX:225220) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Genolution ROCE % Related Terms

Thank you for viewing the detailed overview of Genolution's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genolution (XKRX:225220) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genolution Inc (XKRX:225220) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rm 506, Building A, Beobwon-ro 11-gil, Songpa-gu, Seoul, KOR, 05836

Website

http://www.genolution1.com

Genolution Inc is a biotechnology company that develops and provides RNAi-related products and services. Its products include siRNA, shRNA, miRNA, functional study, transfection, extraction products and detection products.

Genolution (XKRX:225220) Headlines

No Headlines